Dr. Thad Beck, MD
Claim this profileHighlands Oncology
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Thad Beck, MD is currently running
APG-5918
for Cancer
This trial tests a new oral drug, APG-5918, for patients with advanced solid tumors or non-Hodgkin's lymphoma who have no other treatment options. The goal is to find the safest and most effective dose by adjusting it over time and monitoring the patients.
Recruiting1 award Phase 13 criteria
APG-115 + Pembrolizumab
for Skin Cancer
This study aims to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of APG-115, an MDM2 inhibitor, either alone or in combination with pembrolizumab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with metastatic melanomas or advanced solid tumors. Our hypothesis is that restoration of the immune response concomitant to inhibition of the MDM2 pathway (which restores p53 functions) may promote cancer cell death, leading to effective anticancer therapy.
Recruiting1 award Phase 1 & 213 criteria
More about Thad Beck, MD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Thad Beck, MD has experience with
- HQP1351
- APG-115
- Pembrolizumab
- APG-5918
Breakdown of trials Thad Beck, MD has run
Leukemia
Lymphoblastic Leukemia-Lymphoma
Lymphoid Leukemia
Chronic Myelogenous Leukemia
Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thad Beck, MD specialize in?
Thad Beck, MD focuses on Leukemia and Lymphoblastic Leukemia-Lymphoma. In particular, much of their work with Leukemia has involved treating patients, or patients who are undergoing treatment.
Is Thad Beck, MD currently recruiting for clinical trials?
Yes, Thad Beck, MD is currently recruiting for 3 clinical trials in Rogers Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Thad Beck, MD has studied deeply?
Yes, Thad Beck, MD has studied treatments such as HQP1351, APG-115, Pembrolizumab.
What is the best way to schedule an appointment with Thad Beck, MD?
Apply for one of the trials that Thad Beck, MD is conducting.
What is the office address of Thad Beck, MD?
The office of Thad Beck, MD is located at: Highlands Oncology, Rogers, Arkansas 72758 United States. This is the address for their practice at the Highlands Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.